Keppra vs. Esgic-plus: side effect and effectiveness comparison (a real world drug study)
Summary:
We compare the side effects and drug effectiveness of Keppra and Esgic-plus. The phase IV clinical study is created by eHealthMe based on reports (from sources including the FDA) of 217,422 people who take Keppra and Esgic-plus, and is updated regularly.
What is Keppra?
Keppra has active ingredients of levetiracetam. It is often used in epilepsy. eHealthMe is studying from 73,504 Keppra users. Check the latest studies of Keppra.
What is Esgic-plus?
Esgic-plus has active ingredients of acetaminophen; butalbital; caffeine. It is often used in migraine. eHealthMe is studying from 269 Esgic-plus users. Check the latest studies of Esgic-plus.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
217,422 people who take Keppra and Esgic-plus are studied.
Drugs being compared in this study:
- Keppra (levetiracetam)
- Esgic-Plus (acetaminophen; butalbital; caffeine)
Most common side effects of the drugs, overall:
Most common side effects of the drugs, in long term (1+ years) use:
Drug effectiveness:
Keppra:
- not at all: 4.44 %
- somewhat: 13.59 %
- moderate: 22.7 %
- high: 35.51 %
- very high: 23.76 %
Esgic-Plus:
- not at all: 4.44 %
- somewhat: 19.18 %
- moderate: 32.49 %
- high: 30.27 %
- very high: 13.63 %
Want to compare Keppra with Esgic-plus?
- Personalize this study to your gender and age (0-99+)How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related publications that referenced our studies
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
- Schattner A, Al-Bewerat A, "Levetiracetam (Keppra), urinary retention and literature search", A fatty cause of renal failure; what is your diagnosis?, 2016 Oct .
- Spengler DC, Montouris GD, Hohler AD, "Levetiracetam as a possible contributor to acute kidney injury", Clinical therapeutics, 2014 Aug .
- Almeida DM, Jean MR, Chystsiakova A, Monahan E, Oliveira SB, Monteiro IM, "Levetiracetam-associated acute pancreatitis in an adolescent with autism: a case report", Pancreas, 2013 Jan .
Related studies
Alternative drugs to, pros and cons of:
- Keppra (70,381 reports)
- Esgic-plus (239 reports)
Browse all side effects of Keppra:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Esgic-plus:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study is based on levetiracetam and acetaminophen; butalbital; caffeine (the active ingredients of Keppra and Esgic-plus, respectively). Other drugs that have the same active ingredients (e.g. generic drugs or brand names) are also considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Levemir cause Drug Exposure During Pregnancy? - now
- Blood Calcium Increased and drugs of ingredients of mirtazapine - a second ago
- Impaired Healing and drugs of ingredients of bisoprolol fumarate; hydrochlorothiazide - 2 seconds ago
- Drug interactions of Q10 and Profen - 4 seconds ago
- Myasthenia Gravis and Neutrophil Count Increased - 5 seconds ago
- Could Prilosec cause Fluid Overload? - 9 seconds ago
- Drug interactions of Atropine Sulfate and Metronidazole - 9 seconds ago
- Chlorpheniramine Maleate and Ibu drug interactions for women aged 20-29 - 11 seconds ago
- Muscle Atrophy and drugs of ingredients of amphotericin b - 11 seconds ago
- Faeces Discolored and drugs of ingredients of desoximetasone - 11 seconds ago